Matthew Shinkle

Use of sodium-glucose cotransporter-2 inhibitors was linked to significantly reduced risk for adverse kidney, cardiovascular and hepatic outcomes

CHICAGO — Duodenal mucosal resurfacing helped prevent weight regain following tirzepatide discontinuation, according to research presented at Digestive Disease Week.Data from the randomized REMAIN-1 trial showed that individuals who did not undergo duodenal mucosal resurfacing (Revita, Fractyl Health) regained approximately 40% more weight than those who received the investigational

CHICAGO — Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic highlight persistent demographic and socioeconomic disparities, according to a study.Results of the retrospective cohort study showed disproportionate increases in mortality rates among Native American and Hispanic individuals, and higher hospital charges

CHICAGO — Wearable device-derived sleep metrics may help monitor inflammatory bowel disease activity and response to biologic therapy, according to research presented at Digestive Disease Week.

CHICAGO — Patients with irritable bowel syndrome who consumed an elemental diet for 2 weeks reported significant improvement in abdominal

CHICAGO — The number of annual colonoscopies performed in the U.S. is projected to decline over the next decade as use of noninvasive colorectal

CHICAGO — Early treatment with infliximab and an immunomodulator was associated with more than five times reduced risk for abdominal surgery at 5 years among patients with newly diagnosed Crohn’s disease, according to a presenter.Follow-up PROFILE trial data presented at Digestive Disease Week showed that early control of inflammation during a 48-week treatment period also lowered

The FDA has approved an oral combination therapy for certain adults with newly diagnosed acute myeloid leukemia.

CHICAGO — Even as colorectal cancer screening rates have risen among older adults across race and ethnicity, racial disparities in cancer screenings have not improved comparatively, according to data presented at Digestive Disease Week.An analysis of 2015-2023 National Health Interview Surveys showed that despite an annual 1.6% increase in CRC screening overall, individuals who identify as

Several nonantibiotic drugs appear associated with increased risk for Clostridioides difficile infection, according to results of a population-based, case-control study published in Gut.An analysis of data from the Swedish National Patient registry showed antidiarrheals, analgesics and corticosteroids were among nonantibiotic drugs associated with increased risk for C. difficile infection. They